Molecular Imaging and Theranostics in Ovarian Cancer: The Role of Nuclear Medicine
Authors:
Open Access
- 6 August 2022
- book chapter
- Published by Exon Publications
- p. 69-85
Abstract
Ovarian carcinoma remains an important cause of mortality and morbidity, which tends to be diagnosed at an advanced stage due to the non-specific and generalized nature of the symptoms. In this chapter, we review the clinical significance of ovarian cancer, its current diagnosis and treatment and the evolving role of nuclear medicine in the early, non-invasive detection and further management of these patients. We also consider some of the current and future theranostic possibilities in the quest for targeted treatment with fewer systemic side effects.Keywords
This publication has 53 references indexed in Scilit:
- Adnexal Masses Suspected to Be Benign Treated with LaparoscopyJSLS : Journal of the Society of Laparoscopic & Robotic Surgeons, 2012
- Noninvasive assessment of cell proliferation in ovarian cancer using [18F] 3′deoxy-3-fluorothymidine positron emission tomography/computed tomography imagingNuclear Medicine and Biology, 2011
- Early Detection of Recurrent Ovarian Cancer in Patients with Low-Level Increases in Serum CA-125 Levels by 2-[F-18]Fluoro-2-Deoxy- d -Glucose-Positron Emission Tomography/Computed TomographyCancer Biotherapy and Radiopharmaceuticals, 2011
- Diagnostic accuracy of transvaginal ultrasound examination for assigning a specific diagnosis to adnexal massesUltrasound in Obstetrics & Gynecology, 2009
- The impact of PET-CT in suspected recurrent ovarian cancer: A prospective multi-centre study as part of the Australian PET Data Collection ProjectGynecologic Oncology, 2009
- Annual surveillance by CA125 and transvaginal ultrasound for ovarian cancer in both high‐risk and population risk women is ineffectiveBJOG: An International Journal of Obstetrics & Gynaecology, 2007
- No efficacy of annual gynaecological screening in BRCA1/2 mutation carriers; an observational follow-up studyBritish Journal of Cancer, 2007
- Ovarian cancer staging: Does it require a gynecologic oncologist?Gynecologic Oncology, 1992
- Radioimmunoscintigraphy of ovarian cancer with the MOv18 monoclonal antibodyEuropean Journal of Cancer and Clinical Oncology, 1991
- Optimal surgical therapy in stage I and II ovarian malignanciesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1982